Amnestic disorder due to other specified psychoactive substance including medications (Q40295): Difference between revisions

@@ description / pt-br / description / pt-br @@
+Todos os critérios diagnósticos para transtorno amnéstico são preenchidos. Os sintomas de memória são considerados consequência direta do uso de uma substância psicoativa especificada que não álcool; sedativos, hipnóticos ou ansiolíticos; ou inalantes voláteis. A intensidade e duração do uso da substância psicoativa especificada devem ser sabidamente capazes de produzir comprometimento da memória. O comprometimento da memória pode se desenvolver durante ou logo após a intoxicação por ou abstinência da substância psicoativa especificada, mas sua intensidade e duração são significativamente maiores do que aquelas normalmente associadas a essas condições. Os sintomas não são mais bem explicados por outro transtorno ou condição médica, como pode ser o caso se os sintomas amnésticos precederem o início do uso da substância psicoativa especificada.
@@ description / en / description / en @@
+All definitional requirements for amnestic disorder are met. The memory symptoms are judged to be the direct consequence of use of a specified psychoactive substance other than alcohol; sedatives, hypnotics or anxiolytics; or volatile inhalants. The intensity and duration of use of the specified psychoactive substance must be known to be capable of producing memory impairment. The memory impairment may develop during or soon after specified psychoactive substance intoxication or withdrawal, but its intensity and duration are substantially in excess of those normally associated with these conditions. The symptoms are not better accounted for by another disorder or medical condition, as might be the case if the amnestic symptoms preceded the onset of the specified psychoactive substance.
@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/973846324
@@ Property / Canonical URI: https://id.who.int/icd/entity/973846324 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:6D72.12
@@ Property / CURIE: CID11:6D72.12 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-6D72.12
@@ Property / Canary Token: dki-india-6D72.12 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+F10-F19
@@ Property / Linked ICD 10: F10-F19 / rank @@
+Normal rank

Latest revision as of 06:02, 13 August 2026

All definitional requirements for amnestic disorder are met. The memory symptoms are judged to be the direct consequence of use of a specified psychoactive substance other than alcohol; sedatives, hypnotics or anxiolytics; or volatile inhalants. The intensity and duration of use of the specified psychoactive substance must be known to be capable of producing memory impairment. The memory impairment may develop during or soon after specified psychoactive substance intoxication or withdrawal, but its intensity and duration are substantially in excess of those normally associated with these conditions. The symptoms are not better accounted for by another disorder or medical condition, as might be the case if the amnestic symptoms preceded the onset of the specified psychoactive substance.

Language	Label	Description	Also known as
default for all languages	6D72.12
English	Amnestic disorder due to other specified psychoactive substance including medications	All definitional requirements for amnestic disorder are met. The memory symptoms are judged to be the direct consequence of use of a specified psychoactive substance other than alcohol; sedatives, hypnotics or anxiolytics; or volatile inhalants. The intensity and duration of use of the specified psychoactive substance must be known to be capable of producing memory impairment. The memory impairment may develop during or soon after specified psychoactive substance intoxication or withdrawal, but its intensity and duration are substantially in excess of those normally associated with these conditions. The symptoms are not better accounted for by another disorder or medical condition, as might be the case if the amnestic symptoms preceded the onset of the specified psychoactive substance.